You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

PDL1

Showing 51 - 75 of 745
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Resectable Lung Non-Small Cell Carcinoma, Stage I Lung Cancer AJCC v8, Stage IA1 Lung Cancer AJCC v8 Trial in Houston

Terminated
Has Results
  • Resectable Lung Non-Small Cell Carcinoma
  • +10 more
  • Bintrafusp Alfa
  • Therapeutic Conventional Surgery
  • Houston, Texas
    M D Anderson Cancer Center
Jul 27, 2022

Metastatic Solid Tumors, NSCLC, Melanoma Trial in United States (INBRX-105 - PDL1x41BB antibody, Pembrolizumab)

Recruiting
  • Metastatic Solid Tumors
  • +7 more
  • Scottsdale, Arizona
  • +12 more
Jan 26, 2023

Immune Checkpoint Inhibitors (AUTENTIC)

Recruiting
  • Cancer
  • +2 more
  • Treatment with immune checkpoint inhibitors.
  • Blood tests.
  • Vitoria, Álava, Spain
    Hospital Universitario Araba
Aug 27, 2021

Tumor, Esophagus, Malignant Esophagus Tumor, Tumor, Esophageal Trial in Amsterdam (Bintrafusp alfa)

Recruiting
  • Neoplasm, Esophagus
  • +2 more
  • Bintrafusp alfa
  • Amsterdam, Noord-Holland, Netherlands
    Amsterdam UMC
Jan 15, 2021

Bullous Pemphigoid Induced by antiPD-1/PDL-1 Therapy

Unknown status
  • Bullous Pemphigoid
  • +2 more
  • Not concerned
  • Nantes, France
    University Hospital
Nov 18, 2020

Stage III Merkel Cell Carcinoma AJCC v8, Stage IIIB Merkel Cell Carcinoma AJCC v8, Stage IIIA Merkel Cell Carcinoma AJCC v8

Recruiting
  • Stage III Merkel Cell Carcinoma AJCC v8
  • +2 more
  • Orange, California
  • +10 more
Jan 30, 2023

Melanoma (Skin), Non-Small-Cell Lung Carcinoma Trial in Belgium, Spain, United Kingdom (GAd-PEV, MVA-PEV)

Recruiting
  • Melanoma (Skin)
  • Non-Small-Cell Lung Carcinoma
  • GAd-PEV
  • MVA-PEV
  • Charleroi, Belgium
  • +6 more
Feb 23, 2022

Recurrent B-Cell Non-Hodgkin Lymphoma, Refractory B-Cell Non-Hodgkin Lymphoma Trial in France (Selicrelumab, Atezolizumab)

Terminated
  • Recurrent B-Cell Non-Hodgkin Lymphoma
  • Refractory B-Cell Non-Hodgkin Lymphoma
  • Créteil, France
  • +4 more
Jul 23, 2021

Anatomic Stage IV Breast Cancer AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, Hematopoietic and Lymphoid Cell Tumor

Recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +13 more
  • Bintrafusp Alfa
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Jul 14, 2022

NSCLC, Progression, Disease Trial in Paris (Resting Energy Expenditure measurement)

Completed
  • Non-small Cell Lung Cancer
  • Progression, Disease
  • Resting Energy Expenditure measurement
  • Paris, France
    Cochin Hospital
May 10, 2021

PDL1 in Ovarian High Grade Serous Carcinoma

Completed
  • Ovarian Cancer
  • immunohistochemical staining
  • Port Said, Egypt
    Faculty of Medicine, Port Said University
Aug 6, 2020

Metastatic Solid Tumors Trial in Canada, United States (M6223, Bintrafusp alfa)

Recruiting
  • Metastatic Solid Tumors
  • Nashville, Tennessee
  • +3 more
Oct 14, 2021

Cancer, Non Small Cell Lung Cancer, Non Small Cell Lung Cancer Stage III Trial in Worldwide (Durvalumab Injection)

Recruiting
  • Cancer
  • +4 more
  • Durvalumab Injection
  • Tallinn, Estonia
  • +9 more
Dec 1, 2021

Metastatic Renal Cell Carcinoma Trial in Milan (Cabometyx)

Completed
  • Metastatic Renal Cell Carcinoma
  • Milan, Italy
    Fondazione IRCCS Istituto Nazionale Tumori
Apr 23, 2021

Colon Adenocarcinoma, High-Frequency Microsatellite Instability, Metastatic Malignant Solid Tumor Trial in Houston

Active, not recruiting
  • Colon Adenocarcinoma
  • +10 more
  • Anti-PD-L1/TGFbetaRII Fusion Protein M7824
  • Houston, Texas
    M D Anderson Cancer Center
Jan 12, 2022

Carcinoma, Squamous Cell, Oesophageal Cancer Trial in Amsterdam (External beam radiotherapy, Bintrafusp alfa, Paclitaxel)

Recruiting
  • Carcinoma, Squamous Cell
  • Oesophageal Cancer
  • External beam radiotherapy
  • +3 more
  • Amsterdam, Netherlands
    Academic Medical Center, Medical Oncology
Jan 15, 2021

Primary Liver Cancer Trial in Hangzhou (Recombinant Human IL12/15-PDL1B Oncolytic HSV-1 Injection (Vero Cell)))

Recruiting
  • Primary Liver Cancer
  • Recombinant Human IL12/15-PDL1B Oncolytic HSV-1 Injection (Vero Cell))
  • Hangzhou, Zhejiang, China
    The First Affiliated Hospital, Zhejiang University School of Med
Apr 21, 2021

Recurrent Head and Neck Squamous Cell Carcinoma, Second Primary Squamous Cell Carcinoma of the Head and Neck Trial in Houston

Recruiting
  • Recurrent Head and Neck Squamous Cell Carcinoma
  • Second Primary Squamous Cell Carcinoma of the Head and Neck
  • Bintrafusp Alfa
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Nov 17, 2021

Hepatocellular Carcinoma, Thermal Ablation, Anlotinib Trial in Beijing (Anlotinib and TQB2450 solution, TQB2450 solution)

Not yet recruiting
  • Hepatocellular Carcinoma
  • +3 more
  • Anlotinib and TQB2450 solution
  • TQB2450 solution
  • Beijing, Beijing, China
    Chinese PLA General Hospital
Mar 2, 2021

Head and Neck Squamous Cell Carcinoma, Lung Cancer, Oesophageal Cancer Trial in Villejuif (Durvalumab, Tremelimumab, SBRT)

Recruiting
  • Head and Neck Squamous Cell Carcinoma
  • +2 more
  • Villejuif, Val De Marne, France
    Gustave Roussy
Jul 21, 2021

Metastatic Renal Cell Carcinoma, Good or Only One Adverse Prognostic Factor Intermediate Risk Per IMDC Score Trial in France

Not yet recruiting
  • Metastatic Renal Cell Carcinoma
  • Good or Only One Adverse Prognostic Factor Intermediate Risk Per IMDC Score
  • Combination PD-1/PD-L1 ICI + VEGFR-TKI
  • Treatment pause
  • Bayonne, France
  • +24 more
Aug 10, 2022

Advanced Malignant Solid Tumor Trial in ShangHai (Recombinant Human IL12/15-PDL1B Oncolytic HSV-1 Injection (Vero Cell)))

Recruiting
  • Advanced Malignant Solid Tumor
  • Recombinant Human IL12/15-PDL1B Oncolytic HSV-1 Injection (Vero Cell))
  • ShangHai, Shanghai, China
  • +1 more
Apr 26, 2021

Advanced Solid Tumor, NSCLC Trial in Taiwan, United States (NM21-1480)

Recruiting
  • Advanced Solid Tumor
  • Non-small Cell Lung Cancer
  • NM21-1480
  • Pittsburgh, Pennsylvania
  • +3 more
May 18, 2021

NSCLC, Melanoma Trial in London ([99mTc]-NM01 SPECT)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • Melanoma
  • [99mTc]-NM01 SPECT
  • London, United Kingdom
    Guy's and St Thomas' NHS Foundation Trust
Jun 15, 2020

Advanced Lung Non-Small Cell Carcinoma, Stage III Lung Cancer AJCC v8, Stage IIIA Lung Cancer AJCC v8 Trial in Scottsdale,

Active, not recruiting
  • Advanced Lung Non-Small Cell Carcinoma
  • +7 more
  • Scottsdale, Arizona
  • +2 more
Nov 3, 2021